Table 2 CI values of AML samples treated... | American Society of Hematology

Table 2

CI values of AML samples treated with triptolide and TRAIL in vitro

Patient	CI values			Average
Patient	ED₅₀	ED₇₅	ED₉₀	CI	SEM
1	1.42	1.52	1.64	1.52	0.06
2	0.37	0.18	0.10	0.22	0.08
3	42.76	5.32	7.35	18.48	12.15
4	1.11	0.69	0.44	0.74	0.20
5	0.36	0.20	0.12	0.23	0.07
6	18.27	0.59	0.55	6.47	5.90
7	0.68	0.08	0.02	0.26	0.21
8	0.30	0.07	0.02	0.13	0.09
9	0.64	0.44	0.30	0.46	0.10
10	0.79	0.72	0.66	0.72	0.04
11	0.79	0.71	0.63	0.71	0.05
12	202.89	1.06	0.95	68.30	67.29

Patient	CI values			Average
Patient	ED₅₀	ED₇₅	ED₉₀	CI	SEM
1	1.42	1.52	1.64	1.52	0.06
2	0.37	0.18	0.10	0.22	0.08
3	42.76	5.32	7.35	18.48	12.15
4	1.11	0.69	0.44	0.74	0.20
5	0.36	0.20	0.12	0.23	0.07
6	18.27	0.59	0.55	6.47	5.90
7	0.68	0.08	0.02	0.26	0.21
8	0.30	0.07	0.02	0.13	0.09
9	0.64	0.44	0.30	0.46	0.10
10	0.79	0.72	0.66	0.72	0.04
11	0.79	0.71	0.63	0.71	0.05
12	202.89	1.06	0.95	68.30	67.29

Bold type indicates samples showing synergistic effect (CI <1).